This site is intended for health professionals only
Wednesday 29 March 2017
Share |

New haemophilia data at ISTH congress to highlight extension study outcomes and paediatric use

Full results from Kids B-LONG Alprolix® paediatric study to be released for the first time. Interim findings to be presented from ASPIRE, an open label extension study with Eloctate®/Elocta® in adults and children with haemophilia A

Swedish Orphan Biovitrum AB (publ) (Sobi) and collaboration partner Biogen will present 23 company-sponsored platform and poster presentations at the International Society on Thrombosis and Haemostasis (ISTH) 2015 congress taking place in Toronto, Canada, 20–25 June 2015. The data presented underscore the companies' ongoing commitment to haemophilia through continued research within the joint development programmes in haemophilia.

Ads by Google